PT1126853E - Distribuicao controlada de anti-depressivos - Google Patents

Distribuicao controlada de anti-depressivos

Info

Publication number
PT1126853E
PT1126853E PT99971322T PT99971322T PT1126853E PT 1126853 E PT1126853 E PT 1126853E PT 99971322 T PT99971322 T PT 99971322T PT 99971322 T PT99971322 T PT 99971322T PT 1126853 E PT1126853 E PT 1126853E
Authority
PT
Portugal
Prior art keywords
depressions
controlled distribution
triazolones
antidepressants
exemplified
Prior art date
Application number
PT99971322T
Other languages
English (en)
Inventor
Evangeline G Cruz
Yam Noymi
Zhong Adam
Ayer Atul
Bhatt Padmanabh
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT1126853E publication Critical patent/PT1126853E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • External Artificial Organs (AREA)
PT99971322T 1998-11-02 1999-10-26 Distribuicao controlada de anti-depressivos PT1126853E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10675898P 1998-11-02 1998-11-02
US10667798P 1998-11-02 1998-11-02

Publications (1)

Publication Number Publication Date
PT1126853E true PT1126853E (pt) 2006-07-31

Family

ID=26803899

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99971322T PT1126853E (pt) 1998-11-02 1999-10-26 Distribuicao controlada de anti-depressivos

Country Status (13)

Country Link
EP (1) EP1126853B1 (pt)
JP (1) JP4711510B2 (pt)
KR (2) KR20070040421A (pt)
AT (1) ATE323493T1 (pt)
AU (1) AU1230800A (pt)
CA (1) CA2349719C (pt)
CY (1) CY1105463T1 (pt)
DE (1) DE69930952T2 (pt)
DK (1) DK1126853T3 (pt)
ES (1) ES2260962T3 (pt)
HK (1) HK1038515A1 (pt)
PT (1) PT1126853E (pt)
WO (1) WO2000025790A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534238A1 (en) * 2002-07-29 2005-06-01 ALZA Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20040092534A1 (en) * 2002-07-29 2004-05-13 Yam Nyomi V. Methods and dosage forms for controlled delivery of paliperidone
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
US20070259033A1 (en) * 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
ES2124910T3 (es) * 1993-08-31 1999-02-16 Alza Corp Dispensador que contiene un agente hidrofobo.
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
US5990159A (en) * 1996-02-15 1999-11-23 Janssen Pharmaceutica, N.V. Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form

Also Published As

Publication number Publication date
JP2002528505A (ja) 2002-09-03
DE69930952D1 (de) 2006-05-24
KR20010075677A (ko) 2001-08-09
KR100734193B1 (ko) 2007-07-02
CA2349719C (en) 2009-06-02
EP1126853B1 (en) 2006-04-19
DK1126853T3 (da) 2006-08-14
DE69930952T2 (de) 2006-08-31
ES2260962T3 (es) 2006-11-01
HK1038515A1 (en) 2002-03-22
KR20070040421A (ko) 2007-04-16
JP4711510B2 (ja) 2011-06-29
WO2000025790A1 (en) 2000-05-11
EP1126853A1 (en) 2001-08-29
ATE323493T1 (de) 2006-05-15
AU1230800A (en) 2000-05-22
CA2349719A1 (en) 2000-05-11
CY1105463T1 (el) 2010-04-28

Similar Documents

Publication Publication Date Title
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
GB2387696A (en) Real-time odds-based gaming
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
PT1459751E (pt) (s,s)-reboxetina para tratar as enxaquecas
NZ333588A (en) Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
IL147803A0 (en) 28-epirapalogs
ZA977695B (en) 1,4-heterocyclic metalloprotease inhibitors.
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
ZA97927B (en) New substituted oxazolidinones.
UA42795C2 (uk) Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання
BR9703302A (pt) Aparelho e método para a geração e uso de ìons férricos
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
GR3029294T3 (en) Direct-acting hair colouring agent
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
ZA200006978B (en) Agents for controlling plant pests.
ZA200007071B (en) Methods for regulating hematopoiesis using CPG-oligonucleotides.